GlassScriptPhysician profile
Nitin Jayantilal Parikh
NPI 1629070289
$6,316.61
in general payments reported to CMS, 2019-2025
34 companies · $1,576 in 2025
The $1,576 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $374 · 2021: $604 · 2022: $907 · 2023: $820 · 2024: $1,499 · 2025: $1,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,894.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,667.86 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $602.11 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $575.50 | 2019-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $480.49 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Genzyme Corporation | $460.03 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $450.63 | 2019-2025 | Entyvio |
| Intercept Pharmaceuticals, INC. | $269.48 | 2019-2025 | Ocaliva |
| Lilly USA, LLC | $211.24 | 2025 | Omvoh |
| Celgene Corporation | $209.93 | 2021-2024 | Zeposia |
| Ardelyx, INC. | $177.26 | 2023-2025 | Ibsrela |
| Pfizer INC. | $168.81 | 2021-2025 | |
| Romark Laboratories, Lc | $125.83 | 2019-2020 | |
| Daiichi Sankyo INC. | $119.35 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $80.26 | 2019-2022 | |
| Medtronic USA, INC. | $78.73 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $73.23 | 2020-2023 | Sucraid |
| Nestle Healthcare Nutrition INC. | $63.07 | 2021-2022 | |
| Organon LLC | $54.30 | 2024-2025 | Renflexis, Hadlima |
| Madrigal Pharmaceuticals | $52.81 | 2025 | Rezdiffra |
| Medtronic, INC. | $50.13 | 2022-2023 | Bravo |
| Amgen INC. | $38.61 | 2020-2021 | |
| Ucb, INC. | $34.34 | 2019 | |
| Aimmune Therapeutics, INC. | $33.30 | 2024 | |
| Ironwood Pharmaceuticals, INC | $31.42 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $29.76 | 2024 | Iqirvo |
| Phathom Pharmaceuticals, INC. | $26.74 | 2024-2025 | Voquezna |
| Merit Medical Systems INC | $25.89 | 2025 | Esophyx, Big60 Inflation Device |
| Shield Therapeutics INC | $22.57 | 2022 | |
| Merck Sharp & Dohme LLC | $22.03 | 2024 | Dificid |
| Redhill Biopharma INC. | $18.46 | 2022 | |
| Evoke Pharma, INC. | $17.23 | 2022 | |
| Fresenius Kabi USA, LLC | $16.17 | 2023 | Idacio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.89 | 2024 | |
| Braintree Laboratories, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.